Longevity Late Stage Investors & VC Firms
44 firms in this list, with a median first check of $1M. 18 of them lead rounds. Generated from verified public data and updated continuously.
LYFE Capital
Menlo ParkSeed–Late Stage
22 people
Northstar Ventures
Newcastle upon TynePre-Seed–Late Stage$38.1K – $1.3M
17 people
Pontifax Venture Capital
HerzeliyaSeed–Late Stage
7 people
Brookstreet Equity Partners
LondonSeries A–Late Stage
22 people
Camino Partners
AustinGrowth–Late Stage
18 people
Ally Bridge Group
New YorkGrowth–Late Stage
7 people
SDV
LimassolSeed–Late Stage
11 people
Avedon Capital Partners
AmsterdamGrowth–Late Stage
5 people
Avego BioScience Capital
AlpharettaSeries A–Late Stage
2 people
Pandect Bioventures
WoodsideSeed–Late Stage
10 people
naturalX Health Ventures
KarlsruheSeed–Late Stage$3.2M – $5.4M
4 people
Flintera
Growth–Late Stage$10M – $60M
4 people
Gore Range Capital
SouthlakeSeries A–Late Stage$500K – $5M
3 people
Sangel Capital
ShenzhenSeed–Late Stage
2 people
Timeless Partners Ventures
Bal HarbourSeed–Late Stage
3 people
Bas1s Ventures
Series A–Late Stage
Astor Perkins
New YorkSeed–Late Stage
1 person
Elmirate Capital
DubaiSeed–Late Stage$1M – $250M
Boxer Capital, LLC
San DiegoSeed–Late Stage
1 person
Bioscience Equity Partners
DubaiLate Stage
1 person
Related lists
Late Stage Investors & VC Firms (1739)Late Stage Investors & VC Firms in North America (924)Late Stage Investors & VC Firms in United States (821)Late Stage Investors & VC Firms in Global (568)Late Stage Investors & VC Firms in Asia-Pacific (529)Late Stage Investors & VC Firms in Europe (525)Healthtech Late Stage Investors & VC Firms (498)SaaS Late Stage Investors & VC Firms (444)Enterprise Software Late Stage Investors & VC Firms (441)Fintech Late Stage Investors & VC Firms (436)
Data sourced from public filings and firms' own websites — see our methodology.























































